STOCKS TELEGRAPH

Tag: Ocugen Inc.

  • Ocugen, Inc. (OCGN) Stock Losing Momentum in Aftermarket, Here’s the Reason.

    Ocugen, Inc. (OCGN) Stock Losing Momentum in Aftermarket, Here’s the Reason.

    Ocugen, Inc. (OCGN) is a late-stage biotherapeutics company engaged in the discovery, development, and commercialization of gene therapies to treat blindness-related diseases. The company is also developing a COVID-19 vaccine ‘COVAXIN’ in collaboration. The company’s innovative product candidates offer better therapeutics to patients with wet age-related macular degeneration, diabetic macular edema, and, diabetic retinopathy.

    The price of OCGN stock during the regular trading on February 22, 2022, was $4.23 with a gain of 22.2%. At last check in the aftermarket, the stock declined by 12.06%.

    OCGN: Events and Happenings

    On February 22, 2022, OCGN updated the pricing of its underwritten public offering of 15,973,420 million common stock shares. The company expects the net proceeds from the offering of $53.5 million. The offering is expected to close on February 25, 2022. Additionally, the company has granted a 30-day option to the underwriter for the acquisition of up to 2,396,013 million added shares of its common stock.

    On February 22, 2022, OCGN reported about the commencement of an underwritten public offering of the company’s common stock. Additionally, the company expects to grant a 30-day option to acquire an additional 15% of shares of its common stock. The company intends to utilize the gross proceeds for general corporate purposes.

    On February 18, 2022, OCGN informed about hosting a fourth-quarter 2021 earnings release on February 25, 2022. On February 18, 2022, OCGN announced that FDA had lifted the clinical hold on its IND application to assess COVAXIN. On February 15, 2022, survey data from OCGN and The Harris online poll revealed a majority of Americans want more COVID-19 vaccine choices to pick from.

    On January 27, 2022, OCGN updated about signing a non-binding letter of intent with Liminal BioSciences, for the purchase of their manufacturing site in Canada. On January 12, 2022, OCGN and Bharat Biotech announced the results from a study demonstrating that the booster dose of COVAXIN neutralized the Omicron and Delta variants of SARS-CoV-2.

    OCGN: Key Financials

    On November 09, 2021, OCGN released its financial results for the third quarter ended September 30, 2021. Some of the important highlights are discussed below.

    Revenue

    No revenue was reported in Q3 2021 as in the same quarter of 2020.

    EPS

    Basic and diluted net loss per share in Q3 2021 was $10.7 million or $0.05 against $10.4 million or $0.07 in the same period of 2020. The company’s EPS increased over the yearly period. Also, the company missed the analysts’ estimates by -$0.01.

    Conclusion

    OCGN stock is 44% down the past six months due to economic downfall as a result of the pandemic. The current aftermarket fall of the stock was observed after the company announced the pricing of its public offering of common stock. Also, the company is gearing for the earnings release date and the analysts are expecting its EPS to be -$0.07.

  • Here’s why Ocugen, Inc. (OCGN) Stock Leaped Forward in Premarket Session

    Here’s why Ocugen, Inc. (OCGN) Stock Leaped Forward in Premarket Session

    Ocugen, Inc. (OCGN) is a leading innovative clinical-stage biopharmaceutical company. It is primarily focused on the discovery, development, and commercialization of treatments for multiple retinal diseases or blindness and is also under the process of vaccine development for COVID-19 patients. Some of the lead product candidates of the company include OCU400, OCU410, OCU200, and COVAXIN.

    The price of OCGN stock during the regular trading on December 30, 2021, was $4.83 with a significant increase of 10.27%. At last check in the premarket on December 31, 2021, the stock was further up by 1.04%.

    OCGN: Events and Happenings

    On December 30, 2021, OCGN reported that its collaborator Bharat Biotech reported the outcomes of clinical trials of COVID vaccine COVAXIN. The study was executed on children of 2 – 18 years age. The outcomes represented a vigorous counterbalancing antibody response and a promising safe profile on the pre-print server medRXiv. The vaccine was administered in two doses 28-days apart from each other. The outcomes depicted more than a 93% drop in severe conditions. The company had already submitted its application for the status of Emergency Use Authorization on November 5.

    OCGN: CEO Comments

    On this auspicious occasion, Shankar Musunuri, CEO of OCGN said that the above-mentioned data is the first positive vaccine data in children. He further added that the outcomes represented that the vaccine administered in two-doses delivered a robust immune response in children.

    On December 20, 2021, OCGN reported that the compensation committee of BoD approved to acquire a sum of 6,750 shares. The shares belong to its common stock and restricted stock units and cover a sum of 1,150 shares of common stock. The stock options and RSUs were granted as of December 16, in accordance with Nasdaq Listing Rule 5635(c)(4).

    On December 15, 2021, OCGN reported that data studying immune response was published on the preprint server medRvix. The data was taken after two doses of COVAXIN, from a third-party trial. The study confirmed that the vaccine showed a sharp immune memory versus the spike and nucleoproteins of the virus.

    OCGN: Key Financials

    On November 9, 2021, OCGN reported third-quarter 2021 financial results that ended September 30, 2021. Some of the key updates are mentioned below

    Net Loss per Share

    Basic and diluted net loss per share was reported to be $10.7 million or $0.05 per share for Q3 2021 as compared to $10.4 million or $0.07 per share for the same period the prior year.

    Assets

    The total assets of the company reported for Q3 2021 were $113 million as compared to the same period of 2020 when the assets were $19 million.

    Conclusion

    OCGN reported a 23% decline in the stock price as compared to the past month. The current market conditions are favoring the company’s stock as the price of the stock surged in the premarket. The incline was basically the outcome of positive results of the vaccine data in children. The analysts are expecting the company’s stock to skyrocket further in the coming days as a result of this announcement.

  • 35 stocks making the biggest moves premarket today

    35 stocks making the biggest moves premarket today

    FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.

    SCWorx Corp. (NASDAQ: WORX) shares are trading down -6.76% at $2.07 at the time of writing. Company’s 52-week ranged between $1.00 to $14.88.

    Nano Dimension Ltd. (NNDM) lost over -12.1% at $5.74 in pre-market trading Monday, November 30, 2020, after announcing that it has entered into definitive agreements with investors for the sale of 11,960,160 of the Company’s American Depositary Shares (“ADSs”) at a price of $5.00 per ADS pursuant to a registered direct offering.

    Moderna Inc. (MRNA) is up more than 9.38% at $138.95 in pre-market hours on Monday, November 30, 2020 after the firm today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a vaccine efficacy of 94.1%. The stock had jumped over 16.35% to $127.03 in the last trading session.

    FreightCar America Inc. (NASDAQ: RAIL) shares are trading down -3.99% at $2.65 at the time of writing. Company’s 52-week ranged between $0.73 to $2.87. Analysts have a consensus price target of $4.50.

    Blink Charging Co. (BLNK), a Specialty Retail company, dropped about -3.25% at $27.09 in pre-market trading Monday. The firm recently declared that it has acquired the EV charging operator U-Go Stations, Inc. and its portfolio of 44 DCFC charging locations.

    Zomedica Corp. (ZOM), a Drug Manufacturers – Specialty & Generic company, dropped about -1.12% at $0.1324 in pre-market trading Monday.

    GameStop Corp. (GME) is up more than 4.1% at $16.74 in pre-market hours Monday November 30, 2020 after declaring 2020 cyber week deals. The stock had jumped over 9.02% to $16.08 in the last trading session. GameStop Announces 2020 Cyber Week Deals.

    Riot Blockchain Inc. (RIOT) grew over 8.64% at $6.79 in pre-market trading today.

    Verastem Inc. (VSTM) stock moved up 5.03 percent to $2.09 in the pre-market trading after reporting the initiation of a Phase 2 registration-directed clinical trial of VS-6766, its RAF/MEK inhibitor, and defactinib, its FAK inhibitor, in patients with recurrent low-grade serous ovarian cancer (LGSOC).

    Tuniu Corporation (TOUR) gained over 6.58% at $3.4 in pre-market trading on Monday, November 30, 2020. Before the trading started on November 30, 2020.

    Novavax Inc. (NVAX) is down -8.31% to reach $115.25 after providing an update on its COVID-19 vaccine program. NVX‑CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix‑M™. It has been trading in a 52-week range of $3.65 to $189.40.

    Occidental Petroleum Corporation (NYSE: OXY) shares are trading down -2.36% at $16.17 at the time of writing. Company’s 52-week ranged between $8.52 to $47.58. Analysts have a consensus price target of $18.

    RMG Acquisition Corp. (RMG) stock soared 6.6% to $18.1 in the pre-market trading. The firm recently revealed that the close of business on Tuesday, December 1, 2020, has been set as the record date for the determination of stockholders eligible to receive the proxy and vote at the special meeting to be held to consider and approve the previously announced merger with Romeo Systems, Inc., a Delaware corporation.

    Uxin Limited (UXIN) stock soared 2.53% to $1.62 in the pre-market trading. The most recent rating by JP Morgan, on October 23, 2019, is a Neutral.

    ReneSola Ltd (NYSE: SOL) shares are trading up 8.02% at $8.08 at the time of writing. The technology company recently announced the closing of the sale of a portfolio of operating projects located in the United Kingdom to Atmosclear Investments Ltd, an European renewable energy and cleantech private equity group. Company’s 52-week ranged between $0.85 to $5.67. Analysts have a consensus price target of $22.

    Kandi Technologies Group Inc. (KNDI) tumbled over -2.28% at $13.31 in pre-market trading today after CBAK Energy and Kandi Group signed a supply framework agreement.

    Vaxart Inc. (VXRT) is up more than 4.84% at $7.37 in pre-market hours on Monday, November 30, 2020. The stock had jumped over 9.84% to $7.03 in the last trading session. Before the trading started on November 30, 2020.

    Alibaba Group Holding Limited (BABA) is down -2.3% to reach $270.13. The internet retail company has been named a leader in Gartner’s 2020 Magic Quadrant for Cloud Database Management Systems. It has been trading in a 52-week range of $169.95 to $319.32.

    EyePoint Pharmaceuticals Inc. (EYPT) stock soared 1.97% to $0.55 in the pre-market trading. The most recent rating by B. Riley FBR, on April 06, 2020, is a Neutral.

    Canaan Inc. (NASDAQ: CAN) shares are trading down -7.83% at $5.3 at the time of writing after releasing its unaudited financial results for the three months ended September 30, 2020. Company’s 52-week ranged between $1.76 to $8.69.

    Heat Biologics Inc. (NASDAQ: HTBX) shares are trading down -0.88% at $1.13 at the time of writing. Company’s 52-week ranged between $0.19 to $4.30. Analysts have a consensus price target of $4.

    Yunji Inc. (YJ), an Internet Retail company, dropped about -7.35% at $3.53 in pre-market trading Monday. The firm recently declared its unaudited financial results for the third quarter ended September 30, 2020.

    India Globalization Capital Inc. (IGC) gained over 22.63% at $2.33 in pre-market trading Monday November 30, 2020.

    Oramed Pharmaceuticals Inc. (ORMP) stock moved up 38.65 percent to $6.17 in the pre-market trading. The healthcare firm recently reported that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes (T2D). Before the trading started on November 30, 2020.

    Schlumberger Limited (SLB) is down -2.06% to reach $21.43. It has been trading in a 52-week range of $11.87 to $41.14.

    Ocugen Inc. (OCGN) stock plunged -1.71% to $0.294 in the pre-market trading. The firm recently revealed that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen, will speak on “The Promise of Cell & Gene Therapies: Regulatory and Reimbursement Roadblocks” at Xconomy’s Xcelerating Life Sciences New York & Philadelphia Virtual Event on December 3 at 10:30 a.m. Before the trading started on November 30, 2020.

    Gold Fields Limited (GFI) is down -2.52% to reach $8.5. It has been trading in a 52-week range of $3.79 to $14.90. Before the trading started on November 30, 2020.

    Marathon Patent Group Inc. (MARA) is up 15.65% to reach $4.95. It has been trading in a 52-week range of $0.35 to $6.05.

    Kingsoft Cloud Holdings Limited (KC) stock soared 5.13% to $43.69 in the pre-market trading after reporting that it will be included in the MSCI China Index, effective after the U.S. market close on November 30, 2020. The most recent rating by Goldman, on June 29, 2020, is a Buy.

    NanoVibronix Inc. (NASDAQ: NAOV) shares are trading up 5.26% at $0.8 at the time of writing. Company’s 52-week ranged between $0.54 to $3.50.

    Waitr Holdings Inc. (WTRH) stock moved down -1.46 percent to $3.38 in the pre-market trading.

    Hennessy Capital Acquisition Corp. IV (HCAC) gained over 9.0% at $13.69 in pre-market trading on Monday, November 30, 2020.

    Trevena Inc. (TRVN) stock plunged -4.67% to $2.45 in the pre-market trading. The most recent rating by Guggenheim, on September 14, 2020, is a Buy.

    Suncor Energy Inc. (NYSE: SU) shares are trading down -0.58% at $17.15 at the time of writing. The firm lately publicized that it, together with the other Syncrude joint venture owners – Imperial Oil Resources Limited, CNOOC Oil Sands Canada, and Sinopec Oil Sands Partnership – have agreed in principle for Suncor to become the operator of the Syncrude project by the end of 2021. Company’s 52-week ranged between $9.60 to $34.56.

  • 30 hot stocks trending in the pre-market session

    Naked Brand Group Limited (NAKD) stock plunged -4.92% to $0.1603 in the pre-market trading.

    Nano Dimension Ltd. (NASDAQ: NNDM)  shares are trading up 11.74% at $4.95 at the time of writing recently announced prices $100 million registered direct offering. Company’s 52-week ranged between $0.51 to $6.00. Analysts have a consensus price target of $8.

    BIO-key International Inc. (BKYI), a Security & Protection Services company, dropped about -6.14% at $2.75 in pre-market trading Monday after company recently announced that the Board of Directors has approved a 1-for-8 reverse stock split that is expected to become effective on November 20, 2020.

    Eiger BioPharmaceuticals Inc. (EIGR) stock moved up 9.67 percent to $11.0 in the pre-market trading following firm recently revealed that the U.S. Food and Drug Administration (FDA) has approved ZokinvyTM (lonafarnib) for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) and processing-deficient Progeroid Laminopathies (PL).

    Lexicon Pharmaceuticals Inc. (LXRX) is down more than -5.33% at $1.42 in pre-market hours Monday November 23, 2020. The stock had dropped over -3.23% to $1.50 in the last trading session.

    Despegar.com Corp. (DESP), a Travel Services company, dropped about -6.54% at $10.01 in pre-market trading Monday.

    Bristol-Myers Squibb Company (BMY) stock moved up 1.41 percent to $62.48 in the pre-market trading today following announcement of  a discovery collaboration with Bristol Myers Squibb Company (NYSE: BMY) to discover, develop, and commercialize therapeutics in multiple disease areas.

    Niu Technologies (NIU) lost over -5.79% at $33.66 in pre-market trading Monday November 23, 2020 as the firm revealed changes to its board of directors and committees of the Board.

    Nxt-ID Inc. (NXTD) is up more than 8.36% at $0.389 in pre-market hours Monday November 23, 2020. The stock had dropped over -0.28% to $0.36 in the last trading session following the corporation said that it plans to adjourn the Annual Meeting of Stockholders, scheduled to be held on Monday, November 23, 2020 at 9:00 a.m. (Eastern Time), to Tuesday, November 24, 2020 at 9:00 a.m. (Eastern Time), to be held at the Company’s office at 288 Christian Street, Hangar C 2nd Floor, Oxford CT 06478.

    Before the trading started on November 23, 2020, Verb Technology Company Inc. (VERB) is up 9.26% to reach $1.18. It has been trading in a 52-week range of $0.78 to $2.64.

    CIIG Merger Corp. (CIIC) stock soared 13.29% to $19.26 in the pre-market trading.

    RedHill Biopharma Ltd. (NASDAQ: RDHL) shares are trading up 8.89% at $9.8 at the time of writing. Company’s 52-week ranged between $3.26 to $11.35 after announced that it has initiated its Phase 3 study to evaluate the safety and efficacy of RHB-204 as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) – a rare disease for which there is no FDA-approved first-line therapy.

    Xunlei Limited (XNET) gained over 12.0% at $3.08 in pre-market trading Monday November 23, 2020.

    Amarin Corporation plc (AMRN) is down more than -9.74% at $4.17 in pre-market hours Monday November 23, 2020 after shared positive, statistically significant top-line results from Protocol Number EDPC003R01, a Phase 3 clinical trial of VASCEPA® (icosapent ethyl) conducted in China by Amarin partner, Edding. The stock had jumped over 1.76% to $4.62 in the last trading session.

    United Microelectronics Corporation (UMC) grew over 8.65% at $6.28 in pre-market trading today.

    Baozun Inc. (BZUN), a Internet Retail company, dropped about -4.82% at $39.9 in pre-market trading Monday. The firm today announced that its Board of Directors has appointed Mr. Arthur Yu, the Company’s current Vice President of Finance, as Chief Financial Officer (“CFO”), effective December 1, 2020.

    Pioneer Power Solutions Inc. (PPSI) stock moved up 10.49 percent to $4.32 in the pre-market trading.

    SPI Energy Co. Ltd. (SPI) gained over 8.79% at $10.4 in pre-market trading Monday November 23, 2020.

    Bio-Path Holdings Inc. (BPTH) is down more than -0.54% at $3.65 in pre-market hours Monday November 23, 2020 as a result of announcement that the enrollment and dosing of the first patient in a Phase 1 clinical trial evaluating the ability of BP1002 to treat refractory/relapsed lymphoma and chronic lymphocytic leukemia (CLL) patients. The stock had jumped over 9.88% to $3.67 in the last trading session.

    Before the trading started on November 23, 2020, Fuel Tech Inc. (FTEK) is up 19.69% to reach $1.52. It has been trading in a 52-week range of $0.30 to $2.05.

    Medigus Ltd. (MDGS) stock soared 8.48% to $3.07 in the pre-market trading after the firm announced its intention to enter into the electric vehicle and electric charging markets. Medigus signed a non-binding memorandum of understanding with the founders of EMuze to invest in a joint venture, NewCo, for the commercialization of EV micro-mobility vehicles for individual urban use, “last mile” and cargo delivery.

    GreenPower Motor Company Inc. (NASDAQ: GP) shares are trading up 11.34% at $24.54 at the time of writing as the news appeared that the Company has granted an aggregate of 300,000 incentive stock options with 100,000 stock options to each of Brendan Riley, Michael Sieffert and Fraser Atkinson. The stock options are subject to the approval of the TSX Venture Exchange and are exercisable for a period of five years at a price of US $20 per share. Company’s 52-week ranged between $0.82 to $23.45. Analysts have a consensus price target of $22.

    Check-Cap Ltd. (CHEK) grew over 7.1% at $0.38 in pre-market trading today.

    Mesoblast Limited (MESO), a Biotechnology company, rose about 9.8% at $15.13 in pre-market trading Monday after announcement of financial results for the third quarter and nine months ended September 30, 2020

    Titan Pharmaceuticals Inc. (TTNP) stock moved down -5.62 percent to $0.193 in the pre-market trading.

    The9 Limited (NCTY) gained over 21.45% at $3.68 in pre-market trading Monday November 23, 2020 as the company revealed that it will hold its annual general meeting of shareholders at the 17 Floor, No. 130 Wu Song Road, Hong Kou District, Shanghai 200080, People’s Republic of China on December 22, 2020 at 2:00 p.m., Shanghai time.

    Before the trading started on November 23, 2020, CPS Technologies Corporation (CPSH) is up 30.0% to reach $3.12. It has been trading in a 52-week range of $0.88 to $3.35.

    Canaan Inc. (CAN) stock soared 17.52% to $5.03 in the pre-market trading following the company plans to release its third quarter 2020 financial results before the market opens on Monday, November 30, 2020.

    Ferroglobe PLC (GSM), a Other Industrial Metals & Mining company, rose about 24.46% at $1.16 in pre-market trading Monday.

    Ideanomics Inc. (IDEX) stock moved up 37.01 percent to $2.11 in the pre-market trading after the company announced that it has increased its stake in California-based Solectrac, Inc. through a follow-on investment of an additional $1.3 million.